Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for prevention or treatment of graft-versus-host disease in leukemia patients
IRCT20140818018842N27Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in graft-versus-host disease (GVHD), acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), sponsored by Tehran University of Medical Sciences. Started Aug 2015; status: completed.
02
Drugs
atorvastatin
03
Conditions
graft-versus-host disease (GVHD)acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on IRCT20140818018842N27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N27.